MKMasaaki Kai

Masaaki Kai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masaaki Kai has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Takayuki Shibata

    Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences

    14 shared publications
  • Tsutomu Kabashima

    Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan

    14 shared publications
  • Ahmed. F. M. El-Mahdy

    Department of Materials and Optoelectronic Science, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan

    4 shared publications
  • Sheng Yin

    Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan

    4 shared publications
  • Qinchang Zhu

    Faculty of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-Machi, Nagasaki 852-8521, Japan

    3 shared publications
  • Shpend Dragusha

    Nagasaki University

    3 shared publications

Latest Publications

  • Open Access

    Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker

    by Sheng Yin, Tsutomu Kabashima, Qinchang Zhu, Takayuki Shibata, Masaaki Kai

    We developed an assay method for measuring dihydroorotate dehydrogenase (DHODH) activity in cultured HeLa cells and fibroblasts, and in stage III stomach cancer and adjacent normal tissues from the same patient. The assay comprised enzymatic reaction of DHODH with a large amount of dihydroorotic acid substrate, followed by fluorescence (FL) detection specific for orotic acid using the 4-trifluoromethyl-benzamidoxime fluorogenic reagent. The DHODH activities in the biologically complex samples were readily measured by the assay method. Our data indicate significantly higher DHODH activity in HeLa cells (340 ± 25.9 pmol/105 cells/h) than in normal fibroblasts (54.1 ± 7.40 pmol/105 cells/h), and in malignant tumour tissue (1.10 ± 0.19 nmol/mg total proteins/h) than in adjacent normal tissue (0.24 ± 0.11 nmol/mg total proteins/h). This is the first report that DHODH activity may be a diagnostic biomarker for cancer.


  • Open Access

    DNA Aptamers in the Diagnosis and Treatment of Human Diseases

    by Qinchang Zhu, Ge Liu, Masaaki Kai

    Aptamers have a promising role in the field of life science and have been extensively researched for application as analytical tools, therapeutic agents and as vehicles for targeted drug delivery. Compared with RNA aptamers, DNA aptamers have inherent advantages in stability and facility of generation and synthesis. To better understand the specific potential of DNA aptamers, an overview of the progress in the generation and application of DNA aptamers in human disease diagnosis and therapy are presented in this review. Special attention is given to researches that are relatively close to practical application. DNA aptamers are expected to have great potential in the diagnosis and treatment of human diseases.


  • Open Access

    Convenient drug-resistance testing of HIV mutants

    by Masaaki Kai, Qinchang Zhu

    Testing for HIV drug resistance is essential to the care of HIV-infected patients. Although direct phenotypic resistance assays are highly reliable, the current recombinant virus-based method is costly and time-consuming. Here, we report a novel fluorometric assay for phenotypic differentiation of drug-resistant mutants of human immunodeficiency virus-I protease (HIV-PR) which uses enzymatic and peptide-specific fluorescence (FL) reactions and high-performance liquid chromatography (HPLC) of three HIV-PR substrates. This assay enables the use of non-purified enzyme sources and multiple substrates for the enzymatic reaction. In this study, susceptibility of HIV mutations to drugs was evaluated by selective formation of three FL products after the enzymatic HIV-PR reaction. This proof-of-concept study indicates that the present HPLC-FL method could be an alternative to current phenotypic assays for the evaluation of HIV drug resistance.

  • Chemiluminescence-imaging detection of DNA on a solid-phase membrane by using a peroxidase-labeled macromolecular probe

    by Golam Azam, Mutsumi Yamasuji, Tomasz Krawczyk, Takayuki Shibata, Tsutomu Kabashima, Masaaki Kai


  • Sensitive and Selective Determination of Orotic Acid in Biological Specimens Using a Novel Fluorogenic Reaction

    by Sheng Yin, Shpend Dragusha, Valon Ejupi, Takayuki Shibata, Tsutomu Kabashima, Masaaki Kai

    Orotic acid is an intermediate in the synthesis pathway of uridine-5′-monophosphate, and increases in body fluids of patients suffering from hereditary disorders such as orotic aciduria and hyperammonemia. In this study, we developed a spectrofluorometric method with or without high-performance liquid chromatography for the selective and sensitive quantification of orotic acid in human biological specimens, using 4-trifluoromethylbenzamidoxime (4-TFMBAO) as a fluorogenic reagent. This reagent provided intensive fluorescence for only orotic acid amongst 62 compounds including structurally related bio-substances such as nucleic acid bases, nucleosides, nucleotides, amino acids, vitamins, bilirubin, uric acid, urea, creatine, creatinine and sugars. Under optimized reaction conditions, orotic acid was reacted with 4-TFMBAO, K3[Fe(CN)6] and K2CO3 in an aqueous solution. The fluorescence produced from the orotic acid derivative was measured at an excitation of 340 nm and an emission of 460 nm. A concentration of 1.2 μM orotic acid per 1.0 mM creatinine in normal urine and 0.64 nmol orotic acid per 5.0 × 105 HeLa cells were determined by this method. The present method permitted the facile quantification of orotic acid in healthy human urine and cultured HeLa cells by spectrofluorometry and/or high-performance liquid chromatography.


  • Open Access

    Fluorometric assay for phenotypic differentiation of drug-resistant HIV mutants

    by Qinchang Zhu, Zhiqiang Yu, Tsutomu Kabashima, Sheng Yin, Shpend Dragusha, Ahmed F. M. El-Mahdy, Valon Ejupi, Takayuki Shibata, Masaaki Kai

    Convenient drug-resistance testing of viral mutants is indispensable to effective treatment of viral infection. We developed a novel fluorometric assay for phenotypic differentiation of drug-resistant mutants of human immunodeficiency virus-I protease (HIV-PR) which uses enzymatic and peptide-specific fluorescence (FL) reactions and high-performance liquid chromatography (HPLC) of three HIV-PR substrates. This assay protocol enables use of non-purified enzyme sources and multiple substrates for the enzymatic reaction. In this study, susceptibility of HIV mutations to drugs was evaluated by selective formation of three FL products after the enzymatic HIV-PR reaction. This proof-of-concept study indicates that the present HPLC-FL method could be an alternative to current phenotypic assays for the evaluation of HIV drug resistance.


  • Delivery of siRNA using siRNA/cationic vector complexes encapsulated in dendrimer-like polymeric DNAs

    by Ahmed F. M. El-Mahdy, Takayuki Shibata, Tsutomu Kabashima, Qinchang Zhu, Masaaki Kai

    Small interfering RNA (siRNA) is a powerful gene silencing tool and has been considered a potential agent for the treatment of many diseases. However, development of safe and effective siRNA delivery systems still remains a great challenge. In this study, we developed a new siRNA delivery system based on the electrostatic encapsulation of siRNA/cationic vector complexes with dendrimer-like polymeric DNAs (YY-DNAs). The binary complexes of siRNA with cationic vectors such as lipofectamine (LP), polyethylenimine (PEI) and poly-L-lysine (PLL) were first constructed. Then, the encapsulation was performed by the addition of YY-DNAs to the binary complexes in order to form stable complexes of siRNA/LP/YY-DNAs, siRNA/PEI/YY-DNAs and siRNA/PLL/YY-DNAs. The encapsulated siRNA complexes showed nearly spherical morphology with about 13–37 nm average hydrodynamic size and their ζ-potentials were negative. The cationic complexes of siRNA/LP, siRNA/PEI and siRNA/PLL showed a high cytotoxicity towards the cells and strong aggregation with erythrocytes, while their encapsulation into YY-DNAs dramatically decreased the toxicities of complexes. Furthermore, these anionic encapsulated siRNA complexes were highly taken up by the HeLa cells and showed extremely high cellular uptake efficiencies and gene silencing effects without such cytotoxicity and aggregation. The stability of these complexes in 10% FBS and human serum was investigated and they showed high stability even after incubation for 72 h and 48 h, respectively. Therefore, we have newly identified safe and efficient anionic complexes of siRNA for clinical uses.


  • Facile preparation of streptavidin-coated sephadex beads and their application to chemiluminescence detection of a target DNA

    by Ahmed F. M. El-Mahdy, Valon Ejupi, Takayuki Shibata, Tsutomu Kabashima, Jianzhong Lu, Masaaki Kai


  • Open Access

    Amplified and selective assay of collagens by enzymatic and fluorescent reactions

    by Hasina Yasmin, Tsutomu Kabashima, Mohammed Shafikur Rahman, Takayuki Shibata, Masaaki Kai

    Sensitive and selective assay of collagen is of substantial importance to the diagnostic study of health- and aging-related failures. In this paper, we describe a highly specific and sensitive method for the assay of whole collagens in biological samples using a novel fluorogenic reagent, 3,4-dihydroxyphenylacetic acid (3,4-DHPAA). The 3,4-DHPAA reagent can selectively detect N-terminal Gly-containing peptides (NGPs) in the presence of sodium borate and NaIO4. Under conditions optimized, this assay format for collagen, termed 3,4-DHPAA assay method showed a good linear relationship between the amplified FL signals and the collagen concentrations from 0.18 to 12 μg/ml. Therefore the sensitive determination of intracellular collagens in cheek tissue and HeLa cells was individually possible without any separation protocol. The dual recognitions of the collagens in the samples could be performed by the enzymatic digestion and the FL reaction. The proposed assay method enables the determination facile, specific, sensitive and quantitative for biogenic collagens.


  • Selective, sensitive and fluorometric determination of urinary cytosine with 4-trifluoromethylbenzamidoxime and N,N-dimethylformamide

    by Shpend Dragusha, Takayuki Shibata, Sheng Yin, Jun-Ya Fujita, Tsutomu Kabashima, Masaaki Kai